syn0816

Pharmacists and the battle over medical foods

September 10, 2016
Community pharmacists are caught in the middle of a battle between patients and their health insurers over how the federal government defines medical foods and how patients are paying for them.

PBM giants cut drug expenses

September 10, 2016
When Express Scripts and CVS Health announced their 2017 formularies on August 1, a common theme emerged among the healthcare giants: several blockbuster drugs will be removed from both companies’ formularies and lower-cost options such as biosimilars are being embraced.

New dosage form for migraine treatment

September 10, 2016
FDA approved Onzetra Xsail (Avanir Pharmaceuticals Inc.)— a fast-acting, low-dose sumatriptan dry powder formulation for the acute treatment of migraine with or without aura in adults.

A product for every hair-care need

September 10, 2016
Americans spend billions of dollars on products to address specific hair and scalp concerns each year—whether that be color, condition, or appearance.

Biosimilar naming method questioned

September 9, 2016
FDA’s method for naming biosimilars and interchangeable biologics came under fire long before the first biosimilar, Zarxio, was approved last spring.